Related references
Note: Only part of the references are listed.Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au et al.
BLOOD (2009)
Differences between nasal and extranasal NK/T-cell lymphoma
Ritsuro Suzuki et al.
BLOOD (2009)
Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study
Jeeyun Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
Motoko Yamaguchi et al.
CANCER SCIENCE (2008)
Extranodal NK/T-cell lymphoma: diagnosis and treatment cues
Ritsuro Suzuki et al.
HEMATOLOGICAL ONCOLOGY (2008)
Progress in understanding and managing natural killer-cell malignancies
Kazuo Oshimi
BRITISH JOURNAL OF HAEMATOLOGY (2007)
High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases
HJ Kim et al.
BONE MARROW TRANSPLANTATION (2006)
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms
R Suzuki et al.
BONE MARROW TRANSPLANTATION (2006)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Extranodal natural killer/T-cell lymphoma, nasal type - The significance of radiotherapeutic parameters
K Isobe et al.
CANCER (2006)
Leukemia and Lymphoma of Natural Killer Cells
Ritsuro Suzuki
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2005)
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type
TM Kim et al.
BLOOD (2005)
Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: Different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type
Y Nakashima et al.
GENES CHROMOSOMES & CANCER (2005)
Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor) - Prognostication and categorization according to anatomic sites of involvement
R Suzuki et al.
CANCER (2005)
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms
N Murashige et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Nasal-type NK/T cell lymphoma: clinical features and treatment outcome
J Lee et al.
BRITISH JOURNAL OF CANCER (2005)
Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years
WY Au et al.
ANNALS OF ONCOLOGY (2005)
NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status
YH Ko et al.
HISTOPATHOLOGY (2004)
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells
R Suzuki et al.
LEUKEMIA (2004)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma
CC Li et al.
CANCER (2004)
Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore
SB Ng et al.
MODERN PATHOLOGY (2004)
Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma
CY Chen et al.
ANNALS OF ONCOLOGY (2004)
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
CS Chim et al.
BLOOD (2004)
Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value
WY Au et al.
ANNALS OF ONCOLOGY (2003)
L-Asparaginase-based induction therapy for advanced extranodal NK/T-cell lymphoma
K Obama et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma
WB Yong et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Leukemia and lymphoma of natural killer lineage cells
K Oshimi
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma
Y Matsumoto et al.
LEUKEMIA & LYMPHOMA (2003)
Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
S Mraz-Gernhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
WS Kim et al.
ANNALS OF ONCOLOGY (2001)
The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities
M Fujita et al.
PATHOLOGY INTERNATIONAL (2000)
Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment
GE Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases
J Rodriguez et al.
LEUKEMIA & LYMPHOMA (2000)
Share Paper
